Sang Eun Lee

Sang Eun Lee

Auto-generated profile, based on publicly available information

Sang Eun Lee

Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CJChang Wook Jeong
Chang Wook Jeong
JJJin-Woo Jung
Jin-Woo Jung
WCWoo Heon Cha
Woo Heon Cha
BLByung Ki Lee
Byung Ki Lee
SLSangchul Lee
Sangchul Lee
SLSang Eun Lee
Sang Eun Lee
Currently, no standardized method is available to predict success rate after percutaneous nephrolithotomy. We devised and validated the Seoul National University Renal Stone Complexity (S-ReSC) scoring system for predicting the stone-free rate after single-tract percutaneous nephrolithotomy (sPCNL). The data of 155 consecutive patients who underwent sPCNL were retrospectively analyzed. Preoperative computed tomography images were reviewed. The S-ReSC score was assigned from 1 to 9 based on the number of sites involved in the renal pelvis (#1), superior and inferior major calyceal groups (#2–3), and anterior and posterior minor calyceal groups of the superior (#4–5), middle (#6–7), and inferior calyx (#8–9). The inter- and intra-observer agreements were accessed using the weighted kappa (κ). The stone-free rate and complication rate were evaluated according to the S-ReSC score. The predictive accuracy of the S-ReSC score was assessed using the area under the receiver operating characteristic curve (AUC). The overall SFR was 72.3%. The mean S-ReSC score was 3.15±2.1. The weighted kappas for the inter- and intra-observer agreements were 0.832 and 0.982, respectively. The SFRs in low (1 and 2), medium (3 and 4), and high (5 or higher) S-ReSC scores were 96.0%, 69.0%, and 28.9%, respectively (p<0.001). The predictive accuracy was very high (AUC 0.860). After adjusting for other variables, the S-ReSC score was still a significant predictor of the SFR by multiple logistic regression. The complication rates were increased to low (18.7%), medium (28.6%), and high (34.2%) (p = 0.166). The S-ReSC scoring system is easy to use and reproducible. This score accurately predicts the stone-free rate after sPCNL. Furthermore, this score represents the complexity of surgery.

20 November 2008 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
SHSung Kyu Hong
Sung Kyu Hong
BHByung Kyu Han
Byung Kyu Han
SLSeung Tae Lee
Seung Tae Lee
SKSung Soo Kim
Sung Soo Kim
KMKyung Eun Min
Kyung Eun Min
SLSang Eun Lee
Sang Eun Lee

1 October 2014 in Journal of Urology
Verified
Journal Article
Closed access
YPYong Hyun Park
Yong Hyun Park
JLJeong Keun Lee
Jeong Keun Lee
KKKwang Mo Kim
Kwang Mo Kim
HKHa Rim Kook
Ha Rim Kook
HLHansol Lee
Hansol Lee
SLSang Eun Lee
Sang Eun Lee
We investigate the clinicopathological features and prognostic significance of visceral obesity in patients with localized renal cell carcinoma. This study included 706 patients with localized renal cell carcinoma who had undergone curative surgery between January 2003 and April 2012. Visceral, subcutaneous and total adipose tissue were measured based on preoperative computerized tomography of the umbilical region. Visceral adipose tissue percent was calculated using the formula, VAT% = [visceral adipose tissue/total adipose tissue] × 100. The association between clinicopathological factors and visceral obesity was examined. A higher VAT% at diagnosis was associated with older age at diagnosis, higher prevalence of diabetes and higher prevalence of former or current smoking status. The distribution of histological subtypes differed significantly among VAT% quartiles. The proportion of high grade tumors increased as VAT% increased (OR 1.023, 95% CI 1.000-1.126, p = 0.037). A U-shaped association between VAT% quartiles and the risk of disease recurrence was observed for all patients. Disease recurrence was significantly increased in the lowest (HR 3.198, 95% CI 1.765-10.040, p = 0.036) and highest (HR 4.760, 95% CI 2.937-13.210, p = 0.010) VAT% quartiles. Relative visceral obesity as assessed by VAT% was associated with clinicopathological characteristics of localized renal cell carcinoma. A U-shaped association between VAT% quartiles and risk of disease recurrence was observed among patients with localized renal cell carcinoma.

27 April 2010 in BJU International
Verified
Journal Article
Closed access
PDF file
SHSung Kyu Hong
Sung Kyu Hong
SLSeung Tae Lee
Seung Tae Lee
SJSung Jin Jeong
Sung Jin Jeong
SBSeok‐Soo Byun
Seok‐Soo Byun
YHYoung Kwon Hong
Young Kwon Hong
SLSang Eun Lee
Sang Eun Lee

4 August 2009 in BJU International
Verified
Journal Article
Closed access
PDF file
SHSung Kyu Hong
Sung Kyu Hong
SLSeung Tae Lee
Seung Tae Lee
SKSung Soo Kim
Sung Soo Kim
KMKyung Eun Min
Kyung Eun Min
IHIn Sik Hwang
In Sik Hwang
SLSang Eun Lee
Sang Eun Lee

16 April 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HLHakmin Lee
Hakmin Lee
MLMinseung Lee
Minseung Lee
SLSang Eun Lee
Sang Eun Lee
SBSeok-Soo Byun
Seok-Soo Byun
HKHyeon-Hoe Kim
Hyeon-Hoe Kim
SHSung Kyu Hong
Sung Kyu Hong
The prognosis of patients with pathologic stage T3a renal cell carcinoma (RCC) that is up-staged from a small renal tumor remains controversial. We evaluated the prognosis of patients with RCC who were up-staged from clinical stage T1 to pathologic stage T3a. We retrospectively reviewed the data of 3431 patients who were surgically treated for clinical stage T1 RCC. The survival outcomes were compared using Kaplan-Meier and Cox proportional analyses. Among the clinical stage T1 patients, 215 (6.3%) were finally up-staged to pathologic stage T3a. Patient age (HR 1.302, 95% CI 1.018–1.046, p < 0.001), tumor diameter (HR 1.686, 95% CI 1.551–1.834, p < 0.001), and hilar location (HR 1.765, 95% CI 1.147–2.715, p = 0.010) were significantly associated with upstaging. Kaplan-Meier analyses showed significantly shorter recurrence-free, cancer-specific and overall survivals (all p < 0.001) in patients who were up-staged. Multivariate Cox analyses revealed pathologic upstaging as an independent predictor of shorter recurrence-free (HR 2.195, 95% CI 1.459–3.300, p < 0.001), cancer-specific (HR 2.238, 95% CI 1.252–4.003, p = 0.007), and overall survivals (HR 1.632, 95% CI 1.029–2.588, p = 0.037). Subgroup analysis of pathologic stage T3a showed no significant difference in survival of the partial nephrectomy group when compared to the radical nephrectomy group (all p > 0.5). Patients up-staged from clinical stage T1 to pathologic stage T3a RCC showed shorter survival outcomes than those without upstaging. However, partial nephrectomy, compared with radical nephrectomy, showed comparable outcomes in patients who were up-staged.